HRTX
Heron Therapeuti
NASDAQ: HRTX · HEALTHCARE · BIOTECHNOLOGY
$0.35
-2.33% today
Updated 2026-10-02
Market cap
$55.85M
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$0 – $2
Volume
2.5M
Heron Therapeuti (HRTX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.35
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -22.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.